Humetrix : A U.S.-born health AI designed for the world
Founded in the United States, Humetrix has developed precision health AI for over 15 years, tested in crises, deployed at major global events, and now embedded in U.S. public health strategies.
The Origins of Humetrix : A Health AI Pioneer
The story of Humetrix is inseparable from that of its founder, Dr. Bettina Experton. Trained as a physician in France, she completed her medical residency in Paris before earning a doctoral award that brought her to the United States. There, she pursued a career as a physician-scientist and later completed a second residency on American soil in order to practice medicine and became a Public Health Officer in the State of California.
Very quickly, the contrast between healthcare systems proved to be a revelation. “I realized just how different care delivery, and access to care were from one country to another,” she explains.
To better understand these structural gaps, Bettina Experton trained in public health, biostatistics, and epidemiology. It was there that she discovered the transformative potential of digital technologies applied to both individual and population health. She learned to code, developed her first algorithms, and founded Humetrix at a time when artificial intelligence was still far from the spotlight. Her conviction was already clear: “With technology, you can take care of millions of people, not just individual patients one at a time.”
For more than 15 years, Humetrix has established itself as a leader in digital health. Recognized with numerous industry innovation awards from the federal government, the company was the first to develop and deploy a secure mobile medical record application directly on patients’ smartphones. “At the time, the idea that patients could carry their medical records in their pocket seemed almost surreal,” the founder recalls with a smile.
Today, Humetrix is widely regarded as a market leader thanks to its precision public and personal health platforms powered by artificial intelligence, systems designed to operate in real-world conditions, where there is no margin for error
.
Photo : The Humetrix team at CES Las Vegas 2026, with Dr. Bettina Experton at the center (in red). Photo credit : Humetrix.
COVID-19: How Humetrix’s AI Guided Crisis Management in the United States
A major turning point came with the COVID-19 pandemic. As U.S. authorities struggled with a lack of actionable data to anticipate the crisis, Humetrix was directly approached by the Department of Defense Joint Artificial Intelligence Center. “I remember getting a call from the Pentagon on a Sunday. The message was simple: ‘You have the technology to analyze healthcare data, specifically Medicare data; we need to understand where the pandemic is going to hit harder particularly on the most vulnerable populations, including the elderly” recalls Dr. Bettina Experton.
In less than 15 days, the platform was deployed in a secure environment of the Department of Defense analyzing more than 100 million Medicare claim lines per week, covering around 20 million elderly individuals. From this massive volume of data, Humetrix built risk profiles and predictive maps down to the zip code level. These analyses enabled military authorities to determine precisely where to deploy field hospitals, medical staff, vaccination centers, and medical supplies.
The Humetrix models also demonstrated the decline in vaccine effectiveness over time. “These data made it possible to objectively justify booster shots at a time when decisions had to be made very quickly and vaccination data were otherwise lacking” she explains. The work was later published in scientific journals and covered by international media, including in France, giving global reach to analyses originally designed for operational crisis management.
Paris 2024 Olympic Games: Health AI Tested at Scale
Following the pandemic, Humetrix was mobilized during the Paris 2024 Olympic and Paralympic Games, a context marked by massive population flows and extreme linguistic diversity. The platform supported medical care for 15,000 athletes and more than 10 million visitors, facilitating patient intake, triage, and real-time multilingual clinical communication.
The technology relies on validated medical equivalencies (particularly for medications) to prevent prescription errors. “In healthcare, an approximate or erroneous translation can turn into a life-threatening risk. Precision is not a luxury ; it’s an obligation” insists Dr. Bettina Experton.
This experience proved revealing : language barriers are not a peripheral issue but a central challenge in global health security.
International Travelers : Medical AI Serving Global Mobility
Building on the Paris 2024 experience, Humetrix’s use cases have gained increasing traction among airlines, travel insurers, and governments. For travelers living with chronic conditions, severe allergies, or complex treatments, medical information must be immediately understandable, regardless of the country they are in.
Through structured questionnaires and translations based on reliable clinical equivalencies, the platform ensures continuity of medical communication between patients and healthcare providers in host countries. “This is not common world translation. It’s contextualized medical translation” the founder emphasizes.
A strategic advantage for transportation stakeholders and public authorities alike, as international mobility continues to intensify.
CES 2026 : Humetrix at the Heart of U.S. Health Policy
Against this backdrop, Humetrix showcased its technology at CES 2026 in Las Vegas: a multilingual, voice-enabled precision AI platform designed exclusively for medical use. It enables real-time clinical transcription and translation in more than 25 languages, with a medication equivalency database covering over 150 countries, while integrating seamlessly with enterprise analytics tools.
This demonstration comes as the United States accelerates its digital health transformation. Under the leadership of Dr. Mehmet Oz at the helm of the Centers for Medicare and Medicaid Services (CMS), the federal government is making major investments in patient data access, rural health applications, and digital health tools for chronic disease management. CMS oversees a budget of approximately $1.7 trillion and provides coverage to nearly 125 million Americans.
Photo : At the Humetrix booth at CES Las Vegas, Dr. Bettina Experton spoke with Dr. Mehmet Oz, head of the Centers for Medicare and Medicaid Services (CMS). Photo credit : Humetrix.
By the end of 2025, $10 billion of the $50 billion Rural health Transformation program had been redistributed to U.S. states, each receiving more than $200 million to rapidly invest in operational solutions addressing medical deserts. “The States received these federal funds in part to deploy digital solutions that compensate for healthcare workforce shortages and hospital closures in rural areas. They are looking for reliable, immediately deployable technologies. At CES, we had discussions with many state and federal officials to support them in rolling out these health technologies” notes Bettina Experton.
From Humetrix’s pioneering beginnings to COVID-19 crisis management, from Paris 2024 to strategic discussions at CES 2026, the common thread remains clear : a health AI designed for real-world, high-stakes situations at a global scale. “In healthcare, AI only has value if it can be trusted” concludes Dr. Bettina Experton.
A belief that has guided every stage of Humetrix’s development and continues to shape its global ambition.
Camille Colloch